Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Children's Wisconsin, Milwaukee, Wisconsin, USA.
Pediatr Diabetes. 2022 Feb;23(1):55-63. doi: 10.1111/pedi.13275. Epub 2021 Nov 22.
In patients treated for DKA, decrease the rate of visits experiencing one or more BG < 80 mg/dl by 10% within 24 months.
Plan-do-study-act cycles tested interventions linked to key drivers including: standardized DKA guidelines incorporating a two-bag fluid system, efficient ordering process, and care team education. Inclusion criterion: treatment for DKA with a bicarbonate value (HCO ) <15 mEq/L.
the percent of patient visits experiencing a BG < 80 mg/dl while undergoing treatment for DKA. Process measures included: order panel and order set utilization rates. Balancing measures included: emergency department and hospital lengths of stay, time to acidosis resolution (time to HCO ≥ 17 mEq/L), and admission rates. Outcomes were analyzed using statistical process control charts.
From January 2017 through May 2021, our institution treated 288 different patients during 557 visits for suspected DKA. Following our interventions, the overall percent of patient visits for DKA with a BG < 80 mg/dl improved from 32% to 5%. The team did see small improvements in emergency department and hospital lengths of stay; otherwise, there was no significant change in our balancing measures.
Use of quality improvement methodology and standardized DKA management resulted in a significant reduction of BG < 80 mg/dl in patients treated for DKA.
在接受 DKA 治疗的患者中,在 24 个月内将 BG<80mg/dl 的就诊次数减少 10%。
计划-执行-研究-行动(Plan-do-study-act)循环测试了与关键驱动因素相关的干预措施,包括:纳入双袋补液系统的标准化 DKA 指南、高效的医嘱流程以及护理团队教育。纳入标准:HCO3 值<15mEq/L 的 DKA 治疗。
在接受 DKA 治疗期间,BG<80mg/dl 的就诊次数占比。过程测量指标包括:医嘱列表和医嘱集的使用率。平衡测量指标包括:急诊停留时间和住院时间、酸中毒缓解时间(HCO3 值≥17mEq/L)和入院率。使用统计过程控制图分析结果。
从 2017 年 1 月至 2021 年 5 月,我院在 557 次疑似 DKA 就诊中治疗了 288 位不同的患者。在我们的干预措施之后,BG<80mg/dl 的 DKA 就诊总体百分比从 32%提高到 5%。团队确实看到了急诊停留时间和住院时间的微小改善;否则,我们的平衡措施没有明显变化。
使用质量改进方法和标准化的 DKA 管理,显著降低了接受 DKA 治疗的患者的 BG<80mg/dl 水平。